Having trouble viewing this email? View in your browser.

34th Annual ECCMID
28 April 2024 • Barcelona, Spain
Updates in cytomegalovirus and serious Gram-negative infections: Striving for better outcomes

Featured faculty
Andre Kalil
ESCMID appointed chair
University of Nebraska
Medical Center
Omaha, Nebraska, USA
Roy Chemaly
MD Anderson Cancer Center
Houston, Texas, USA
Souha Kanj
American University of
Beirut Medical Center
Beirut, Lebanon
Genovefa Papanicolaou
Memorial Sloan Kettering
Cancer Center
Weill Cornell Medical College
New York, New York, USA
Klemens Budde
Charite University
Berlin, Germany
Ryan Shields
University of Pittsburgh
Medical Center
Pittsburgh, Pennsylvania, USA
Sundeep Kaul
Harefield Hospital
Uxbridge, UK

Symposium sponsored by MSD

Sunday, 28 April 2024

13:30 - 15:30 (CEST)

Agenda Details Speaker
13:30 – 13:33 Welcome and introduction  Andre Kalil, Roy Chemaly
13:33 – 14:31 Part 1: Advancements in CMV management: Examining past, present, and future strategies in HSCT and solid organ transplantation
13:33 – 13:35 Opening remarks Roy Chemaly
13:35 – 13:53 CMV prophylaxis in HSCT: Past, present, and future Genovefa Papanicolaou
13:53 – 14:11 New frontiers in CMV prophylaxis in solid organ transplantation: State of the art update Klemens Budde
14:11 – 14:31 Panel discussion and Q&A All with moderators: Roy Chemaly and Andre Kalil
14:31 – 15:29 Part 2: Emerging strategies in the management of nosocomial pneumonia in critically ill patients: Addressing the challenge of MDR pathogens
14:31 – 14:33 Opening remarks Souha Kanj
14:33 – 14:51 Unraveling the evolving landscape of resistance: Recent updates and novel findings Ryan Shields
14:51 – 15:09 Unveiling real-world evidence: Lessons learned from managing patients failing initial antibacterial therapy Sundeep Kaul
15:09 – 15:29 Panel discussion and Q&A All with moderators: Souha Kanj and Andre Kalil
15:29 – 15:30 Closing remarks Andre Kalil, Souha Kanj
Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates.
All rights reserved. HQ-NON-00891 04/24 -5347444-2

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.